Clinical Trials Logo

Tobacco Use clinical trials

View clinical trials related to Tobacco Use.

Filter by:

NCT ID: NCT03527030 Recruiting - Tobacco Use Clinical Trials

Cross-Sectional Survey on the Use of Tobacco Products - London (UK)

Start date: March 5, 2018
Phase:
Study type: Observational

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in London, United Kingdom.

NCT ID: NCT03527017 Recruiting - Tobacco Use Clinical Trials

Cross-Sectional Survey on the Use of Tobacco Products - Germany

Start date: March 12, 2018
Phase:
Study type: Observational

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Germany.

NCT ID: NCT03527004 Recruiting - Tobacco Use Clinical Trials

Cross-Sectional Survey on the Use of Tobacco Products - Italy

Start date: March 20, 2018
Phase:
Study type: Observational

The main purpose of the research study is to estimate the prevalence of tobacco product use and describe the tobacco use patterns in adults in Italy.

NCT ID: NCT03477435 Not yet recruiting - Tobacco Use Clinical Trials

Comparing an Opt-out to an opt-in Approach for Smoking Cessation in VA Primary Care Clinics

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

The investigators propose a Type I hybrid effectiveness/implementation study to evaluate two population-based approaches for increasing use of Quitlines and text messaging at two VA sites. Specifically, the investigators will test the default bias, examining whether an opt-out approach to referral is more effective than an opt-in approach. The investigators will randomly assign teams to either an opt-out or opt-in approach to referring smokers to treatment. In the opt-out approach, the default is that everyone is referred to treatment unless they actively choose not to be. In the opt-in approach, people are offered treatment but must actively choose to enroll in it.

NCT ID: NCT03476837 Not yet recruiting - Tobacco Use Clinical Trials

Reducing Tobacco Exposures Among African American Women and Children

Start date: June 1, 2019
Phase: N/A
Study type: Interventional

Secondhand smoke exposure in the home can causes sudden infant death syndrome (SIDS), asthma, respiratory illnesses, and ear infections in children. In addition to cigarette smoke, exposure to other tobacco products can further compromise the safety of children in the home. This study aims to reduce the burden of multiple tobacco exposures, improve access to preventive care, and reduce the disproportionate risk for chronic diseases, including cancer, among African American women and children living in the Arkansas Delta region. Our central hypothesis is that messages delivered by a community health worker that aim to modify knowledge, attitudes, beliefs, and subjective norms may influence the perceived threat of tobacco exposures and provide cues for African American women caregivers to implement comprehensive smokefree policies to protect their children from the harms of tobacco and in-turn, influence their quitting.

NCT ID: NCT03463837 Recruiting - Tobacco Use Clinical Trials

Identify Biomarkers of Tobacco Exposure and Nicotine Uptake From JUUL 5% in Adult Smokers

Diamond
Start date: March 6, 2018
Phase: N/A
Study type: Interventional

The JUUL 5% Electronic Nicotine Delivery System (ENDS) is being studied as an alternative to combustible cigarette use. This study aims to find out how much nicotine is in the blood and urine of healthy adult subjects after using three JUUL 5% ENDS compared to smoking usual brands of combustible cigarettes and stopping smoking.

NCT ID: NCT03453385 Not yet recruiting - Smoking Clinical Trials

Clinical Outcomes of a Nationwide, Naturalistic E-Cig Trial (CONNECT)

CONNECT
Start date: May 1, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to measure changes in smoking behavior during and following sampling of an e-cigarette product. E-cigarettes are classified by the US Food and Drug Administration (FDA) as a tobacco product, though they contain no tobacco. Unlike regular cigarettes, which are burned (creating smoke that is inhaled), e-cigarettes include a heating element that vaporizes nicotine. E-cigarettes are likely much safer than conventional cigarettes, but they may not be entirely safe. We are testing the effects of one specific ecigarette (NJoy) on naturalistic changes in smoking behavior. Neither the tobacco industry nor any ecigarette manufacturer provides support of any kind to this study. There is no requirement to quit smoking in this study, nor is there any requirement to use e-cigarettes.

NCT ID: NCT03446170 Recruiting - Tobacco Use Clinical Trials

Effect of Cigarette Pack Warnings and Packaging Among Young Adult Smokers

Start date: September 1, 2014
Phase: N/A
Study type: Interventional

The objective of this study is to examine whether cigarette packaging regulations including graphic health warning labels on cigarette packs and requiring plain, unbranded packaging reduce the appeal of cigarettes and prompt young adult smokers to quit.

NCT ID: NCT03427372 Not yet recruiting - Tobacco Use Clinical Trials

The Effect of Tobacco Use and Psychological State on Post Spinal Puncture Headache and Backache

Start date: February 2018
Phase: N/A
Study type: Observational

To investigate the effect of patient mood and cigarette smoking before spinal anesthesia on post spinal puncture headache and backache

NCT ID: NCT03413423 Recruiting - Clinical trials for Acute Coronary Syndrome

Post Acute Cardiac Event Smoking (PACES) Study

Start date: January 29, 2018
Phase: N/A
Study type: Interventional

Summary of the Project : Quitting smoking following acute coronary syndrome (ACS) can reduce mortality up to 50%. However, depression and smoking are highly co-morbid and depressed mood may interfere with cessation and independently predicts mortality. Thus, a single, integrated treatment for both smoking and depression could be highly effective in reducing post-acute coronary syndrome mortality. Behavioral Activation (BA) is a well established treatment for depression and has recently shown promise as a treatment for smoking cessation. The investigators systematically developed an intervention integrating gold standard smoking cessation counseling with existing BA based mood management techniques for post-ACS smokers; Behavioral Activation Treatment for Cardiac Smokers (BAT-CS). Objective: For this R01 the investigators will evaluate the efficacy of using a single, integrated treatment that targets both depressed mood and smoking (BAT-CS).